Lv0
0 积分 2024-02-05 加入
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)
21天前
已完结
CAR T-cells in multiple myeloma: the race to the start line
21天前
已完结
Efficacy and Safety Comparisons of Four Approved Chimeric Antigen Receptor T‐Cell Therapies in Multiple Myeloma
21天前
已完结
The importance of ABO in platelet refractoriness, an often overlooked option
5个月前
已完结
ABO‐mismatched platelet and plasma transfusion practices and the potential for transfusion‐related alpha‐gal syndrome: The Biomedical Excellence for Safer Transfusion Collaborative Study
5个月前
已完结
How I use noninvasive prenatal testing for red blood cell and platelet antigens
5个月前
已完结
皖公网安备34019202002308
